BHC
HealthcareBausch Health Companies Inc.
$7.40
+$0.19 (+2.64%)
Jan 5, 2026
Price History (1Y)
Analysis
Bausch Health Companies Inc. is a healthcare company operating in the specialty and generic drug manufacturing industry. It has a significant presence with a market capitalization of $2.75 billion, revenue of $10.03 billion, and approximately 20,700 employees. The company's financial health indicates relatively high profitability, with gross margin at 70.7%, operating margin at 26.7%, and profit margin at 3.6%. Bausch Health also has substantial returns on equity (563.2%) and assets (4.8%). Its balance sheet shows a debt-to-equity ratio of 5910.67, indicating significant leverage. Additionally, the company has a cash reserve of $1.31 billion against total debt of $21.04 billion. The company's valuation metrics include a price-to-earnings ratio (TTM) of 7.40 and forward P/E of 1.76. Revenue growth over the past year was 6.8%. Dividend information is not available, and payout ratio is 0.0%. The beta coefficient measures volatility at 0.37.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Bausch Health Companies Inc.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Visit website →Key Statistics
- Market Cap
- $2.75B
- P/E Ratio
- 7.40
- 52-Week High
- $8.69
- 52-Week Low
- $4.25
- Avg Volume
- 2.50M
- Beta
- 0.37
Company Info
- Exchange
- NYQ
- Country
- Canada
- Employees
- 20,700